Alfred Jonczyk

4.5k total citations · 2 hit papers
33 papers, 3.8k citations indexed

About

Alfred Jonczyk is a scholar working on Immunology and Allergy, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Alfred Jonczyk has authored 33 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology and Allergy, 16 papers in Molecular Biology and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Alfred Jonczyk's work include Cell Adhesion Molecules Research (20 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Chemical Synthesis and Analysis (7 papers). Alfred Jonczyk is often cited by papers focused on Cell Adhesion Molecules Research (20 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Chemical Synthesis and Analysis (7 papers). Alfred Jonczyk collaborates with scholars based in Germany, United States and United Kingdom. Alfred Jonczyk's co-authors include Simon L. Goodman, Horst Kessler, Beate Diefenbach, Günter Hölzemann, Roland Haubner, Eckart Planker, Barbara Mathä, Elisabeth Lohof, Michael A. Dechantsreiter and Rainer Gratias and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Alfred Jonczyk

33 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

N-Methylated Cyclic RGD Peptides as Highly Active and Selective α_Vβ₃Integrin Antagonists

1999 721 citations Günter Hölzemann, Alfred Jonczyk et al. Journal of Medicinal Chemistry profile →
Structural and Functional Aspects of RGD-Containing Cyclic Pentapeptides as Highly Potent and Selective Integrin α_Vβ₃Antagonists

1996 500 citations Roland Haubner, Beate Diefenbach et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alfred Jonczyk Germany	24	2.1k	1.7k	706	649	475	33	3.8k
Beate Diefenbach Germany	12	1.2k 0.6×	1.5k 0.9×	708 1.0×	315 0.5×	355 0.7×	14	2.6k
Florian Rechenmacher Germany	23	1.4k 0.7×	1.0k 0.6×	385 0.5×	432 0.7×	430 0.9×	33	2.6k
Ute Reuning Germany	34	1.8k 0.9×	1.3k 0.8×	534 0.8×	1.2k 1.8×	446 0.9×	83	4.3k
Jay S. Desgrosellier United States	19	2.7k 1.3×	1.7k 1.0×	415 0.6×	1.6k 2.5×	546 1.1×	30	4.9k
Ryan J. Park United States	29	1.2k 0.6×	665 0.4×	1.3k 1.9×	744 1.1×	258 0.5×	59	3.0k
Enrica Balza Italy	29	1.4k 0.7×	1.1k 0.7×	1.1k 1.5×	898 1.4×	159 0.3×	56	3.1k
W. Gregory Roberts United States	24	2.5k 1.2×	676 0.4×	435 0.6×	784 1.2×	1.7k 3.7×	30	5.5k
Zhaofei Liu China	40	1.6k 0.8×	944 0.6×	1.8k 2.6×	1.4k 2.2×	1.4k 2.9×	119	5.0k
Johannes Notni Germany	32	865 0.4×	896 0.5×	1.6k 2.2×	929 1.4×	265 0.6×	83	3.2k
Laura Borsi Italy	37	2.1k 1.0×	2.0k 1.2×	1.5k 2.1×	1.4k 2.1×	158 0.3×	74	4.9k

Countries citing papers authored by Alfred Jonczyk

Since Specialization

Citations

This map shows the geographic impact of Alfred Jonczyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred Jonczyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred Jonczyk more than expected).

Fields of papers citing papers by Alfred Jonczyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfred Jonczyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred Jonczyk. The network helps show where Alfred Jonczyk may publish in the future.

Co-authorship network of co-authors of Alfred Jonczyk

This figure shows the co-authorship network connecting the top 25 collaborators of Alfred Jonczyk. A scholar is included among the top collaborators of Alfred Jonczyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfred Jonczyk. Alfred Jonczyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Patsenker, Eleonora, Yury Popov, Felix Stickel, et al.. (2008). Inhibition of Integrin αvβ6 on Cholangiocytes Blocks Transforming Growth Factor-β Activation and Retards Biliary Fibrosis Progression. Gastroenterology. 135(2). 660–670. 161 indexed citations

Finnegan, Eileen M., et al.. (2007). Small-molecule cyclic αVβ3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion. American Journal of Physiology-Heart and Circulatory Physiology. 293(2). H1038–H1045. 21 indexed citations

Strieth, Sebastian, Martin Eichhorn, Arne Sutter, et al.. (2006). Antiangiogenic combination tumor therapy blocking α_v‐integrins and VEGF‐receptor‐2 increases therapeutic effects in vivo. International Journal of Cancer. 119(2). 423–431. 27 indexed citations

Pallu, Stéphane, Chantal Bourget, Reine Bareille, et al.. (2005). The effect of cyclo-DfKRG peptide immobilization on titanium on the adhesion and differentiation of human osteoprogenitor cells. Biomaterials. 26(34). 6932–6940. 29 indexed citations

Meyer, J., Alfred Jonczyk, Horst Kessler, et al.. (2002). RGD-peptides for tissue engineering of articular cartilage. Biomaterials. 23(16). 3455–3463. 111 indexed citations

Castel, Susanna, Roser Pagan, Francesc Mitjans, et al.. (2001). RGD Peptides and Monoclonal Antibodies, Antagonists of αv-Integrin, Enter the Cells by Independent Endocytic Pathways. Laboratory Investigation. 81(12). 1615–1626. 77 indexed citations

Mitjans, Francesc, Tim Meyer, Claus Fittschen, et al.. (2000). In vivo therapy of malignant melanoma by means of antagonists of αv integrins. International Journal of Cancer. 87(5). 716–723. 127 indexed citations

Kantlehner, Martin, Patricia Schaffner, Dirk Finsinger, et al.. (2000). Surface Coating with Cyclic RGD Peptides Stimulates Osteoblast Adhesion and Proliferation as well as Bone Formation. ChemBioChem. 1(2). 107–114. 250 indexed citations

DeNardo, Sally J., Peter Burke, Bryan R. Leigh, et al.. (2000). Neovascular Targeting with Cyclic RGD Peptide (cRGDf-ACHA) to Enhance Delivery of Radioimmunotherapy. Cancer Biotherapy and Radiopharmaceuticals. 15(1). 71–79. 44 indexed citations

10.

Kamm, Walter, et al.. (2000). Evaluation of absorption enhancement for a potent cyclopeptidic ανβ3-antagonist in a human intestinal cell line (Caco-2). European Journal of Pharmaceutical Sciences. 10(3). 205–214. 27 indexed citations

11.

Mitjans, Francesc, Tim Meyer, Claus Fittschen, et al.. (2000). In vivo therapy of malignant melanoma by means of antagonists of alphav integrins.. PubMed. 87(5). 716–23. 148 indexed citations

12.

Diefenbach, Beate, et al.. (1999). Definition of an Unexpected Ligand Recognition Motif for αvβ6 Integrin. Journal of Biological Chemistry. 274(4). 1979–1985. 125 indexed citations

13.

Kantlehner, Martin, Dirk Finsinger, J. Meyer, et al.. (1999). Selective RGD-Mediated Adhesion of Osteoblasts at Surfaces of Implants. Angewandte Chemie International Edition. 38(4). 560–562. 109 indexed citations

14.

Storgard, Chris, Dwayne G. Stupack, Alfred Jonczyk, et al.. (1999). Decreased angiogenesis and arthritic disease in rabbits treated with an αvβ3 antagonist. Journal of Clinical Investigation. 103(1). 47–54. 266 indexed citations

15.

Hammes, Hans‐Peter, Michael Brownlee, Alfred Jonczyk, Arne Sutter, & Klaus T. Preissner. (1996). Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor–type integrins inhibits retinal neovascularization. Nature Medicine. 2(5). 529–533. 271 indexed citations

16.

Kessler, Horst, Beate Diefenbach, Dirk Finsinger, et al.. (1995). Design of superactive and selective integrin receptor antagonists containing the RGD sequence. Letters in Peptide Science. 2(3-4). 155–160. 52 indexed citations

17.

Brodin, Ernst, Annika Rosén, Elvar Theodorsson, et al.. (1994). Multiple molecular forms of tachykinins in rat spinal cord: a study comparing different extraction methods. Regulatory Peptides. 52(2). 97–110. 9 indexed citations

18.

Raddatz, Peter, et al.. (1992). Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'. Journal of Medicinal Chemistry. 35(19). 3525–3536. 17 indexed citations

19.

Hölzemann, Günter, et al.. (1991). Conformation‐based design of two cyclic physalaemin analogues. Biopolymers. 31(6). 691–697. 4 indexed citations

20.

Jonczyk, Alfred & Hans‐Gregor Gattner. (1981). Einde neue Semisynthese des Humanindulins. Tryptisch-katalysierte Transpeptidierung von Schweineinsulin mit L-Threonin-tert-butylester.. Hoppe-Seyler´s Zeitschrift für physiologische Chemie. 362(2). 1591–1598. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact